# US 2023/0416763 A1 · Storing and/or transporting extracellular nucleic acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0416763 A1
- Document ID: US20230416763A1
- Status: Published application
- Kind: A1
- Application number: 18/037,119
- Filed: 2021-11-12
- Published: 2023-12-28
- Earliest claimed: 2020-11-16
- Applicants: Atelerix Limited
- Inventors: Dean HALLAM; Stephen SWIOKLO; Che CONNON
- Web page: https://patentgrep.com/patent/US20230416763A1

## CPC

- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- C12N 15/68: Stabilisation of the vector
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 2710/10351: Methods of production or purification of viral material
- C12N 2740/15051: Methods of production or purification of viral material
- C12N 2770/20051: Methods of production or purification of viral material
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides a reversibly cross-linked hydrogel comprising a sample, wherein the sample comprises extracellular nucleic acid. Corresponding methods of preparing, transporting and/or storing the nucleic acid-containing hydrogel, as well as uses thereof, are also provided herein.

## Claims

### Claim 1

A reversibly cross-linked hydrogel comprising a sample, wherein the sample comprises extracellular nucleic acid.

### Claim 2 (depends on 1)

The hydrogel of claim 1, wherein the extracellular nucleic acid is within a lipid capsule.

### Claim 3 (depends on 1)

The hydrogel of claim 1, wherein the extracellular nucleic acid is in a viral vector or a viral particle.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The hydrogel of claim 1, wherein the sample further comprises an aqueous buffer, optionally wherein the aqueous buffer is a salt-based buffer.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel comprises cross-linked alginate, optionally wherein the hydrogel comprises cross-linked calcium-alginate, strontium-alginate, barium-alginate, magnesium-alginate and/or sodium-alginate.

### Claim 8 (depends on 7)

The hydrogel of claim 7, wherein the cross-linked alginate comprises from about (w/v) to about 5.0% (w/v) calcium alginate.

### Claim 9 (depends on 1)

The hydrogel of claim 1, wherein the extracellular nucleic acid is RNA or DNA.

### Claim 10 (depends on 1)

The hydrogel of claim 1, wherein the hydrogel is packaged in a sealed receptacle, optionally wherein the sealed receptacle is a vial, tube, flask, dish, vessel, or plate.

### Claim 11

(canceled)

### Claim 12

A method of preparing a sample comprising extracellular nucleic acid for storage and/or transportation from a first location to a second location, the method comprising the steps of:
i) contacting the sample with a hydrogel-forming polymer; and
ii) polymerising the polymer to form a reversibly cross-linked nucleic acid-containing hydrogel.

### Claim 13 (depends on 12)

The method of claim 12, further comprising mixing the extracellular nucleic acid with an aqueous buffer prior to step (i), optionally wherein the aqueous buffer is a salt-based buffer.

### Claim 14 (depends on 12)

The method of claim 12, wherein the method comprises sealing the nucleic acid-containing hydrogel into a receptacle for storage or transportation from the first location to the second location, optionally wherein the sealed receptacle is a vial, tube, flask, dish, vessel, or plate; and optionally wherein the method further comprises iii) dispatching the sealed receptacle for transportation from the first location to the second location.

### Claim 15

(canceled)

### Claim 16 (depends on 1)

A method of transporting a sample comprising an extracellular nucleic acid from a first location to a second location, the method comprising the steps of:
(a) obtaining a reversibly cross-linked nucleic acid-containing hydrogel generated by i) contacting the sample with a hydrogel-forming polymer; and ii) polymerising the polymer to form a reversibly cross-linked nucleic acid-containing hydrogel; or obtaining a reversibly cross-linked nucleic acid-containing hydrogel according to claim 1;
(b) transporting the hydrogel from the first location to the second location; and
(c) optionally releasing the nucleic acid from the hydrogel at the second location.

### Claim 17

(canceled)

### Claim 18 (depends on 1)

A method of storing a sample comprising an extracellular nucleic acid, the method comprising the steps of:
(a) obtaining a reversibly cross-linked nucleic acid-containing hydrogel generated by i) contacting the sample with a hydrogel-forming polymer; and ii) polymerising the polymer to form a reversibly cross-linked nucleic acid-containing hydrogel; or obtaining a reversibly cross-linked nucleic acid-containing hydrogel according to claim 1;
(b) storing the hydrogel; and
(c) optionally releasing the nucleic acid from the hydrogel after storage.

### Claim 19

(canceled)

### Claim 20 (depends on 1)

A method for fulfilling an order or request for an extracellular nucleic acid, the method comprising the steps of:
a) receiving an order or request for an extracellular nucleic acid;
b) obtaining a reversibly cross-linked nucleic acid-containing hydrogel generated by i) contacting the sample with a hydrogel-forming polymer; and ii) polymerising the polymer to form a reversibly cross-linked nucleic acid-containing hydrogel; or obtaining a reversibly cross-linked nucleic acid-containing hydrogel according to claim 1; and
c) dispatching the sample for transportation; or transporting the sample to the location specified in the order or request.

### Claim 21 (depends on 12)

The method of claim 12, wherein the extracellular nucleic acid is within a lipid capsule.

### Claim 22 (depends on 12)

The method of claim 12, wherein the extracellular nucleic acid is in a viral vector or a viral particle.

### Claim 23

(canceled)

### Claim 24 (depends on 12)

The method of claim 12, wherein the sample further comprises an aqueous buffer, optionally wherein the aqueous buffer is a salt-based buffer.

### Claim 25

(canceled)

### Claim 26 (depends on 12)

The method of claim 12, wherein the hydrogel comprises cross-linked alginate, optionally wherein the hydrogel comprises cross-linked calcium-alginate, strontium-alginate, barium-alginate, magnesium-alginate and/or sodium-alginate.

### Claim 27 (depends on 26)

The method of claim 26, wherein the cross-linked alginate comprises from about (w/v) to about 5.0% (w/v) calcium alginate.

### Claim 28 (depends on 12)

The method of claim 12, wherein the extracellular nucleic acid is RNA or DNA.

### Claim 29

(canceled)
